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Summary
Zika virus (ZIKV) remained obscure until the recent explosive outbreaks in French Polynesia 
(2013-2014) and South America (2015-2016). Phylogenetic studies reveal that ZIKV has evolved 
into African and Asian lineages. The Asian lineage of ZIKV is responsible for the recent 
epidemics in the Americas. However, the underlying mechanisms through which ZIKV rapidly 
and explosively spread from Asia to the Americas are limited. We have recently shown that 
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nonstructural protein 1 (NS1) facilitates flavivirus acquisition by mosquitoes from an infected 
mammalian host and subsequently enhances viral prevalence in mosquitoes. Here, we report that 
the antigenemia of NS1 determines ZIKV infectivity in its mosquito vector Aedes aegypti, which 
acquires ZIKV via a blood meal. Clinical isolates from the most recent outbreak in the Americas 
were much more infectious in mosquitoes than the FSS13025 strain, which was isolated in 
Cambodia in 2010. Further analyses showed that these epidemic strains have more robust NS1 
antigenemia than the FSS13025 strain because of an alanine-to-valine amino acid substitution at 
the 188th residue in NS1. ZIKV infectivity was enhanced by this residue substitution in the ZIKV 
FSS13025 strain in mosquitoes that acquired ZIKV from a viremic Type I and II interferon 
receptor-deficient (ifnagr-/-) C57BL/6 (AG6) mouse. Our results reveal that ZIKV evolved to 
acquire a spontaneous mutation in its NS1 protein, resulting in increased antigenemia of the 
protein. Enhancement of NS1 antigenemia in infected hosts promotes ZIKV infectivity and 
prevalence in mosquitoes, which potentially facilitates transmission during the recent ZIKV 
epidemics.
Zika virus (ZIKV), a mosquito-borne virus belonging to the genus Flavivirus of the family 
Flaviviridae, is transmitted to humans by Aedes mosquito species1,2. Several neurological 
complications, such as Guillain-Barré syndrome in adults3 and microcephaly in neonates4, 
are potentially associated with ZIKV infection. Before 2007, cases of ZIKV infection were 
only sporadically detected2,5. The first reported mild ZIKV outbreak occurred in 2007 on a 
Western Pacific Micronesian Yap Island6. In 2013, a larger ZIKV epidemic was recorded in 
French Polynesia and other Southern Pacific islands7,8. In 2015, ZIKV emerged in the 
Americas for the first time, rapidly spreading to 20 countries or territories9. Phylogenetic 
studies have revealed that ZIKV has evolved into African and Asian clusters2,9. Sequence 
analyses revealed that the ZIKV strains causing earlier outbreaks in Micronesia (2007) and 
French Polynesia (2013-2014) and later outbreaks in the Americas (2015-2016) all belong to 
the Asian clade2, suggesting that increased infectivity of the Asian ZIKV lineage might 
contribute to the recent worldwide epidemic.
Evolutionary enhancement of infectivity of mosquito-borne viruses within their vectors 
results in high epidemic potential10,11. We speculate that the adaptability and infectivity of 
ZIKV within its mosquito vectors might have evolved with time, contributing to the 
prevalence and spread of the virus from Asia to the Americas. To test this hypothesis, we 
compared the viral infectivity of two clinical ZIKV isolates of the Asian lineage, GZ01 
isolated in 201612 and FSS13025 in 201013, in the primary urban mosquito vector, Aedes 
aegypti. Phylogenetic analysis shows that these 2 strains represent the clades corresponding 
to the epidemic strains of ZIKV that are prevalent in Americas (2015-2016) and the 
Southeastern Asia (2007-2012) (Extended Data Fig. 1). Thus, we exploited a "host-
mosquito" acquisition model to assess the infectivity of these ZIKV strains, via mosquitoes 
acquiring ZIKV from a viremic AG6 mouse 14–16 (Fig. 1a). Both strains exhibited similar 
replication kinetics in the infected AG6 mouse blood (Fig. 1b). However, the serum level of 
secreted nonstructural protein 1 (NS1) in the FSS13025-infected AG6 mice was much lower 
(Fig. 1c). The infected mice were subjected to daily biting by the Rockefeller laboratory 
strain of A. aegypti from days 1 to 5 post-mouse infection (Fig. 1a). Compared to the GZ01 
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strain, the FSS13025 strain had a significantly lower infection prevalence in the mosquitoes 
that fed on the infected mice (Fig. 1d, e).
Secretion of NS1, a virus-encoded nonstructural protein, into the serum of an infected host is 
a common property of many flaviviruses15,17–20. Our previous study demonstrated that 
circulating NS1 acquired by mosquitoes together with virions when mosquitoes feed on a 
viremic mammalian host enhances viral infectivity15. NS1 antigenemia plays a key role in 
maintaining the flavivirus life cycle15. We hypothesize that NS1 antigenemia is responsible 
for the differential mosquito infectivity between the GZ01 and FSS13025 strains. We 
therefore infected Vero cells with the American isolates GZ01 and PRVABC5921, the SZ01 
strain representing the French Polynesian clade22, and the FSS13025 strain. Three post-
epidemic strains showed higher NS1 secretion than the FSS13025 strain (Fig. 2a–c), even 
when NS1 amount was normalized to viral titer (Fig. 2c).
To determine whether NS1 secretability correlates with ZIKV infectivity in mosquitoes, we 
generated a murine NS1 polyclonal antibody (Extended Data Fig. 2a). Neutralization of NS1 
via the antibody treatment reduced the mosquito infection prevalence of the GZ01 strain 
(Fig. 2d–f). The murine NS1 antibodies did not neutralize ZIKV virions (Extended Data Fig. 
3). We also determined whether the addition of NS1 protein could enhance ZIKV infectivity. 
A recombinant GZ01 NS1 protein was expressed and purified using a Drosophila S2 
expression system (Extended Data Fig. 2b). The presence of NS1 increased the infectivity of 
the FSS13025 strain in mosquitoes (Fig. 2g–i). We next assessed the threshold concentration 
of NS1 that can effectively enhance ZIKV acquisition. Compared to BSA, the presence of 
100 ng/ml or higher concentrations of NS1 significantly increased the ZIKV prevalence in 
A. aegypti (Fig. 2j–l). To determine the role of animal NS1 antigenemia in ZIKV infectivity 
in mosquitoes, we allowed mosquitoes to feed on viremic AG6 mice (Extended Data Fig. 
4a). The NS1 antisera treatment reduced the quantity of circulating NS1 in mouse serum 
(Extended Data Fig. 4b) but did not influence GZ01 ZIKV replication in AG6 mice 
(Extended Data Fig. 4c). The infection ratios of fed A. aegypti were reduced as a result of 
the antisera-mediated neutralization of the NS1 in mice (Extended Data Fig. 4d, e).
Considering the differential secretability of NS1 between the GZ01 and FSS13025 strains 
(Fig. 1c and Fig. 2a–c), we next attempted to identify the amino acids critical for NS1 
secretion. We focused on the ER transmembrane region of pre-Membrane (prM), the full 
length of Envelope (E), and NS1 (prM-E-NS1)23 (Fig. 3a). There are only two variable sites 
between the GZ01 and FSS13025 prM-E-NS1 proteins, including the 473rd residue in the E 
protein (Val/FSS13025 to Met/GZ01) and the 188th residue in the NS1 protein (Ala/
FSS13025 to Val/GZ01) (Fig. 3a). We therefore individually subcloned the prM-E-NS1 
region from the GZ01 and FSS13025 strains and subsequently transfected these segments 
into 293T cells. Ectopic expression of the GZ01 prM-E-NS1 protein, but not the FSS13025 
protein, led to abundant NS1 secretion in the supernatants of transfected cells (Fig. 3b). 
Mutation from valine to methionine at the 473rd residue of the E protein in the FSS13025 
prM-E-NS1 protein did not improve NS1 secretion; however, the alanine to valine 
substitution at the NS1 188th residue rendered NS1 secretable (Fig. 3b), demonstrating that 
this single mutation determines NS1 secretability. The 188th residue is located within 
interface between two NS1 monomers24 (Extended Data Fig. 5a). Nonetheless, the alanine-
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to-valine substitution at position 188 does not influence NS1 dimerization (Extended Data 
Fig. 5b), suggesting that the mechanism how the single mutation affects NS1 remains to be 
defined.
We next performed an alignment of the NS1 proteins from the Asian clade of ZIKV. In 
ZIKV isolates collected before 2012, the 188th residue of the NS1 protein is an alanine. 
However, this residue is mutated to valine in all isolates after 2013 (Extended Data Fig. 6), 
suggesting that the Asian linage of ZIKV evolved to acquire NS1 secretability when it 
spread from Southeastern Asia to the Southern Pacific islands around 2013. 
Correspondingly, Singapore reported local ZIKV transmission in August 2016. The 
Singaporean strains stemmed from an ancestral node of the Asian lineage25. Indeed, in all 
ZIKV isolates from Singapore, the 188th residue of the NS1 protein is a valine (Extended 
Data Fig. 6), suggesting that the alanine-to-valine substitution may have contributed to the 
recent ZIKV epidemics. Therefore, we synthesized the prM-E-NS1 genes from a Malaysia 
P6-740 strain isolated in 1966 and a Micronesian 2007 strain and ectopically expressed these 
genes in 293T cells. Compared to the secretion of NS1 in the supernatants of GZ01 prM-E-
NS1-transfected cells, the NS1 protein was hardly detectable in the supernatants of these 
pre-epidemic ZIKV prM-E-NS1-expressing cells (Fig. 3c). However, the alanine-to-valine 
mutation in the NS1 protein of the P6-740 strain conferred NS1 secretability (Fig. 3d).
Next, we created the alanine-to-valine mutation at the 188th position of the NS1 protein in an 
infectious clone of the FSS13025 strain (FSS13025-A188V)26. The substitution significantly 
increased NS1 secretion in the supernatant of infected Vero cells (Extended Data Fig. 7a–c). 
The FSS13025-A188V strain showed higher ZIKV infectivity in mosquitoes than wild type 
virus (Extended Data Fig. 7d, e). In the "mouse-mosquito" acquisition model, NS1 
antigenemia was increased in the sera of FSS13025-A188V ZIKV-infected mice (Fig. 3e). 
Mutation of the NS1 188th position did not influence viral infectivity or dissemination 
kinetics in infected AG6 mouse blood (Fig. 3f). However, the substitution enhanced ZIKV 
transmission from mice to mosquitoes (Fig. 3g, h). Moreover, neutralization of NS1 with 
murine ZIKV NS1 antisera effectively reduced the prevalence of FSS13025-A188V ZIKV in 
mosquitoes (Extended Fig. 8a–d), highlighting that the 188th valine in NS1 has a critical role 
in the antigenemia, which is critical for ZIKV acquisition by mosquitoes.
We next investigated whether NS1-mediated enhancement of ZIKV infectivity influences 
the prevalence of ZIKV-carrying mosquitoes using a "mosquito-mouse-mosquito" 
transmission cycle. We thoracically inoculated an equal titer (5 pfu) of the GZ01, FSS13025 
and FSS13025-A188V mutant strains, into female A. aegypti mosquitoes. Six days 
following virus inoculation, two infected mosquitoes were allowed to feed on AG6 mice 
(Fig. 4a). The mosquito-bitten animals developed high-titer viremia of all three ZIKV strains 
(Fig. 4b). Replication of both the GZ01 and FSS13025-A188V ZIKV strains, but not the 
FSS13025 strain, resulted in efficient NS1 antigenemia (Fig. 4c). Subsequently, the infected 
mice were subjected to daily biting by naïve A. aegypti from days 1 to 8 post-mouse 
infection (Fig. 4a). Through a complete transmission cycle, the FSS13025-A188V strain 
showed a significantly higher prevalence of mosquito infection than did the FSS13025 strain 
(Fig. 4d, e), demonstrating that the 188th valine is required for the generation of NS1 
antigenemia which enhances ZIKV transmissibility from hosts to vectors.
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ZIKV independently separated into African and Asian lineages. We found that the 188th 
residue in all ZIKV African strains is valine (Extended Data Fig. 9a). The Uganda MR766-
infected Vero cells abundantly secreted NS1 (Extended Data Fig. 9b–d), implicating that 
infection of the African ZIKV might produce high NS1 antigenemia. ZIKV has two 
ecologically distinct transmission cycles: a sylvatic cycle (mosquitoes to non-human 
primates) and a human cycle (mosquitoes to humans)27. Knowledge of ZIKV before 2012 
was almost exclusively centered on the enzootic sylvatic cycle in Africa27,28. A mosquito 
survey in Africa showed that ZIKV was detected in mosquitoes collected in multiple 
surveyed landscapes, except for indoor locations within villages28. Therefore, we 
hypothesize that the presence of the NS1 188th valine might bestow the African lineage of 
ZIKV with a highly efficient enzootic or epizootic transmission cycle27,28. Other unknown 
factor(s) might prevent African ZIKV from efficiently establishing a human cycle. However, 
the Asian strains may have evolved to target humans with high infectivity; indeed, one such 
strains caused a medium-scale epidemic in Micronesia in 20072,6. The alanine-to-valine 
substitution at position 188 further improved ZIKV transmission efficiency from humans to 
mosquitoes and thus increased its prevalence in mosquitoes. Our data offer a potential 
explanation for the recent re-emergence of ZIKV, and suggest that coevolution of 




Human blood for mosquito feeding was taken from healthy donors who provided written 
informed consent. The collection of human blood samples was approved by the local ethics 
committee at Tsinghua University.
Mice, mosquitoes, cells and viruses
AG6 mice were donated from Institute Pasteur of Shanghai, Chinese Academy of Sciences5. 
The mice were bred and maintained under a specific pathogen-free animal facility at 
Tsinghua University. Groups of age- and sex-matched AG6 mice, 6–8 weeks of age, were 
used for the animal studies15. All experiments were approved by and performed under the 
guidelines of the Experimental Animal Welfare and Ethics Committee of Tsinghua 
University. A. aegypti (Rockefeller strain) were reared in a low-temperature, illuminated 
incubator (Model 818, Thermo Electron Corporation, Waltham, MA) at 28 °C and 80% 
humidity according to standard rearing procedures29. The ZIKV GZ01 strain (KU820898), 
PRVABC59 (KU501215), SZ01 strain (KU866423), MR766 (NC_012532) and FSS13025 
strain (KU955593) were grown in Vero cells for blood meals15. The Drosophila 
melanogaster S2 cell line was cultured in Schneider’s medium with 10% heat-inactivated 
fetal bovine serum and 1% antibiotic–antimycotic (15240-062, Invitrogen). The Vero cells 
and 293T cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) 
supplemented with 10% heat-inactivated fetal bovine serum (16000-044, Gibco). For ZIKV 
infection, the Vero cells were maintained in VP-SFM medium (11681-020, Gibco). The Vero 
and 293T cell lines were purchased from the ATCC (CCL-81, CRL-3216). The Drosophila 
S2 cell line was sourced from a Drosophila expression system of Invitrogen (R690-07). 
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None of these cell lines were found in the database of commonly misidentified cell lines 
maintained by ICLAC and NCBI Biosample. All these cell lines were authenticated by 
ATCC or Invitrogen and do not have mycoplasma contamination. ZIKV was titered by a 
plaque formation (PFU) assay29.
Antibodies
The ZIKV NS1 genes were amplified from the cDNA of infected cells and cloned into a 
pET-28a (+) expression vector (69864, Millipore). The cloning primers are presented in 
Extended Data Table 1. Recombinant NS1 proteins were expressed in the Escherichia coli 
BL21 DE3 strain in an insoluble form in inclusion bodies. The proteins were then 
solubilized by 8 M urea and purified with a TALON Purification Kit (635515, Clontech). 
Murine antisera were produced via the inoculation of recombinant ZIKV NS1 with 3 boosts. 
Polyclonal antibodies were purified from the immunized antisera using Protein A/G agarose 
(20423, Thermo). The anti-V5-HRP antibody for tag detection were purchased from 
Invitrogen (R96125, Thermo).
Expression of prM-E-NS1 protein in human cells
The prM-E-NS1 regions (820 bp-3438 bp in GZ01 KU820898; 927 bp-3544 bp in 
FSS13025 KU955593) were amplified from cDNA of infected cells. The prM-E-NS1 genes 
from the P6-740 strain (820 bp-3438 bp, HQ234499) and the Micronesian 2007 strain (820 
bp-3438 bp, EU545988) were commercially synthesized (Genescript, China). All the genes 
were subcloned into a pcDNA3.1/V5-His/TOPO DNA vector (K4800-01, Invitrogen), and 
subsequently transfected by the X-treme Gene HP DNA transfection reagent (06366236001, 
Roche) for ectopically expression in 293T cells. The amount of NS1 was determined in the 
supernatants of the 293T cells at 48 hrs post-transfection. The cloning primers are shown in 
Extended Data Table 1.
ZIKV NS1 protein generation in a Drosophila expression system
The ZIKV NS1 gene was cloned into a pMT/BiP/V5-His A vector (V4130-20, Invitrogen) 
for expression in Drosophila S2 cells. The cloning primers are shown in Extended Data 
Table 1. The procedure for ZIKV NS1 expression and purification in a Drosophila 
expression system has been described in our previous studies15,29.
ZIKV NS1 detection by ELISA
Secretion of ZIKV NS1 into Vero cell supernatant and mouse serum was measured using a 
ZIKV NS1 Antigen ELISA Kit (ZIKV-NS1-EK, BioFront MonoTrace). The experiment was 
performed according to the kit’s manual. Samples were diluted to the range of quantification 
of the kit using the sample dilution buffer provided in the kit. Standard materials for the 
generation of a standard curve were also provided in the kit. The measured amount of ZIKV 
NS1 matched the linearity in the assay. Optical density (OD) was measured at 450 nm with 
an ELISA reader (Varioskan Flash Multimode Reader, Thermo Scientific). The detection 
limit of NS1 protein by ELISA is 0.1 ng/ml.
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Thoracic inoculation of ZIKV in mosquitoes
Detailed procedures for microinjection in mosquitoes have been described by our previous 
studies15,30. Briefly, the female A. aegypti mosquitoes were anesthetized on a cold tray, and 
subsequently a certain titer of ZIKV was microinjected into the mosquito thoraxes. The 
infected mosquitoes were used for ZIKV transmission to AG6 mice by a blood meal.
Membrane blood feeding
Fresh human blood was placed in heparin-coated tubes (367884, BD Vacutainer) and 
centrifuged at 1,000×g and 4 °C for 10 min to separate the plasma from the blood cells. The 
plasma was collected and heat-inactivated at 55 °C for 60 min. The separated blood cells 
were washed 3 times with PBS to remove the anticoagulant. The cells were then 
resuspended in the heat-inactivated plasma. The donor's sera were negative for detection of 
the E and NS1 proteins of JEV, DENV and ZIKV. Either purified proteins or antibodies were 
mixed with the ZIKV-infected supernatant and human blood for mosquito oral feeding via a 
Hemotek system (6W1, Hemotek Limited, England). Engorged female mosquitoes were 
transferred into new containers and maintained under standard conditions for an additional 8 
days. The mosquitoes were subsequently sacrificed for further analysis.
Mosquito feeding on infected mice
Eight to ten female A. aegypti mosquitoes were separated into a netting-covered container 
for blood feeding. The mosquitoes were starved for 24 hr before engorgement. ZIKV-
infected AG6 mice were anesthetized and placed on top of the container. The mosquitoes 
were allowed to feed on the mice for 30 min in the dark. After anesthetization using ice, the 
engorged mosquitoes were transferred to new containers and maintained under standard 
conditions for an additional 8 days. The mosquitoes were subsequently sacrificed for further 
analysis.
Purification of infectious ZIKV virions
The procedure of purification of flaviviral infectious virions has been described in our 
previous study15. Briefly, supernatant from GZ01-infected Vero cells was collected 5 days 
after infection. Cell fragments were removed by centrifugation at 25,000×g and 4 °C for 20 
min. Subsequently, the supernatant was carefully transferred into a clean centrifuge tube and 
centrifuged at 25,000×g and 4 °C for an additional 6 h to pellet the virions. The precipitated 
virions were washed twice and then solubilized in VP-SFM medium (11681-020, Gibco). 
Insoluble material was removed by an extra centrifugation step at 12,000×g and 4 °C for 2 
min. The virions in the VP-SFM medium were aliquoted and stored at -80 °C.
Viral genome quantitation by TaqMan qPCR
Total RNA was isolated from homogenized mosquitoes using an RNeasy Mini Kit (74106, 
Qiagen) and reverse-transcribed into cDNA using an iScript cDNA synthesis kit (170-8890, 
Bio-Rad). Viral genomes were quantified via TaqMan qPCR amplification of ZIKV genes, 
normalized against A. aegypti actin (AAEL011197). The detection limit of ZIKV E/Actin 
mRNA ratio is 0.001. The primers and probes used for this analysis are shown in Extended 
Data Table 1.
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Determination of the virus titer in infected mice by plaque assay
Blood samples were collected from the tail veins of infected mice in 0.4% sodium citrate 
and were centrifuged for 5 min at 6,000×g and 4 °C for plasma isolation. The presence of 
infectious viral particles in the plasma was determined using a plaque assay15. The detection 
limit in the plaque assay is 10 pfu/ml in cell supernatant, and 100 pfu/ml in serum.
RNA transcription, transfection and virus recovery
The pFLZIKV-FSS13025 and pFLZIKV-FSS13025-A188V26 plasmids were amplified in E. 
coli Top10 (C404010, Invitrogen) and purified using MaxiPrep PLUS (12965, QIAGEN). 
For in vitro transcription, 10 μg of plasmid was linearized with the restriction enzyme ClaI. 
A mMESSAGE mMACHINE T7 kit (AM1344, Ambion) was used for in vitro transcription 
of RNA in a 20 μl reaction with an additional 1 μl of 30 mM GTP solution. The RNA was 
precipitated with lithium chloride and quantified via spectrophotometry. Subsequently, the 
RNA was transfected into Vero cells seeded in a T175 flask with DMEM medium and 
incubated at 37°C and 5% CO2 using Lipofectamine 3000 reagent (L3000015, Invitrogen). 
Recombinant viruses in cell culture media were harvested 4 days post transfection, stored in 
aliquots at -80°C, and subjected to further investigation.
Statistics
Animals were randomly allocated into different groups. Mosquitoes that died before 
measurement were excluded from analysis. The investigators were not blinded to the 
allocation during the experiments or to the outcome assessment. No statistical methods were 
used to predetermine the sample size. Descriptive statistics have been provided in the figure 
legends. Kruskal-Wallis analysis of variance was conducted to detect any significant 
variation among replicates. If no significant variation was detected, the results were pooled 
for further comparison. Given the nature of the experiments and the type of samples, 
differences in continuous variables were assessed with a non-parametric Mann-Whitney test. 
Differences in mosquito infective rates were analyzed using Fisher’s exact test. p values 
were adjusted using Bonferroni correction to account for multiple comparisons. All analyses 
were performed using GraphPad Prism statistical software.
Data availability
Source data for the main and Extended Data Figures are provided in the online version of 
this paper. All other data are available from the corresponding authors upon reasonable 
request.
Liu et al. Page 8














Extended Data Figure 1. Phylogenetic analysis of ZIKV isolates in the Asian lineage
The tree was constructed using the neighbor-joining (NJ) method based on the alignment of 
ZIKV sequences in the Asian lineage. The bootstrap values of 2000 replicates are indicated 
on the branch nodes.
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Extended Data Figure 2. Generation of murine anti-ZIKV NS1 polyclonal antibody and 
purification of the GZ01 ZIKV NS1 protein from Drosophila S2 cells
a, Generation of murine anti-ZIKV NS1 polyclonal antibody. A murine ZIKV NS1 
polyclonal antibody was generated by immunization of the purified GZ01 ZIKV NS1 
recombinant protein expressed in E. coli. The antibody was validated by probing an S2-
expressed ZIKV NS1 recombinant protein. The same samples probed by murine pre-
immune antibody served as a negative control.
b, Purification of the GZ01 ZIKV NS1 protein from Drosophila S2 cells. Full-length NS1 
was cloned into the pMT/BiP/V5-His A expression vector. Recombinant ZIKV NS1 protein 
was expressed in Drosophila S2 cells and purified using a cobalt-His column (Left Panel). 
Protein quality was evaluated by Western-blotting with an anti-V5 antibody (Right Panel).
a, b, The experiments were reproduced 3 times with similar results. For gel source data, see 
Supplementary Fig. 1.
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Extended Data Figure 3. Anti-ZIKV NS1 antibodies did not neutralize ZIKV virions
We premixed two dilutions of murine ZIKV NS1 polyclonal antisera (1:100 and 1:1000) 
with purified ZIKV GZ01 infectious virions. The same amount of pre-immune sera served 
as a negative control. After a 30 min incubation, the infectivity of the "antibody-ZIKV 
virion" mixture was determined by plaque assay on Vero cells. The values in the graph 
represent the mean ± s.e.m. p values were determined by two-tailed Mann-Whitney test. The 
data were combined from 3 biological repeats. n.s., not significant.
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Extended Data Figure 4. Passive transfer of ZIKV NS1 antibodies into infected AG6 mice 
prevented ZIKV acquisition by A. aegypti
a, Schematic representation of the study design. AG6 mice were intradermally infected with 
1×104 pfu of the ZIKV GZ01 strain. Subsequently, 100 μl of a murine ZIKV NS1 antibody 
was intraperitoneally inoculated into the mice 12 hr post-infection. The same amount of pre-
immune serum was inoculated as a mock control. After 12 hr of antibody dissemination, the 
infected mice were subjected to daily biting by female A. aegypti from day 1 to day 5 post-
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mouse infection. The mouse blood-fed mosquitoes were reared for an additional 8 days for 
ZIKV detection.
b, ZIKV NS1 measurement by ELISA (n=6 mice per group pooled from 3 independent 
biological replicates). Mouse sera were collected to quantify the amounts of ZIKV NS1 
protein from days 0 and 6 post-mouse infection.
c, Detection of the ZIKV load in the blood of the infected mice (n=8 mice per group pooled 
from 4 independent biological replicates). The presence of infectious ZIKV particles in 
blood plasma was determined by a plaque assay from days 0 to 6 post-mouse infection.
d, e, Immuno-blockade of ZIKV NS1 in infected AG6 mice reduced the infection of fed A. 
aegypti (n=6 mice per group pooled from 3 independent biological replicates). The number 
of infected mosquitoes relative to the total number of mosquitoes is shown at the top of each 
column. Each dot represents a mosquito (d). The data are represented as the percentage of 
mosquito infection (e).
Data are mean ± s.e.m. (b, c). p values were determined by two-tailed Mann-Whitney test 
(b-d) or two-sided Fisher’s exact test (e). **p< 0.01, ***p< 0.001, n.s., not significant.
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Extended Data Figure 5. Modeling the location of the 188th residue of ZIKV NS1 and assessing 
NS1 dimer formation in cell lysates
a, Modeling the location of the 188th residue of ZIKV NS1. Modeling was based on the 
ZIKV NS1 structure (PDB: 5K6K)30. The 188th position is located within the interface of a 
NS1 dimer (contoured by red), which is formed by hydrophobic interactions. The 188th 
amino acid is deep within the hydrophobic pocket formed by Trp-210, Leu-23, His-299 and 
Leu-231.
b, Assessing NS1 dimer formation in the lysates of cells transfected with GZ01 or 
FSS13025 prM-E-NS1 recombinant plasmids. The cell lysates, with or without heating 
treatment, were used for assessing NS1 monomer and dimer by Western blotting with an 
anti-V5 antibody, respectively. The experiment was reproduced 3 times with similar results. 
For gel source data, see Supplementary Fig. 1.
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Extended Data Figure 6. 
Sequence alignment of NS1 sequences in ZIKV isolates of the Asian lineage.
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Extended Data Figure 7. A single amino acid substitution enhanced NS1 secretability and ZIKV 
infectivity in mosquitoes
a–c, NS1 secretability in ZIKV-infected Vero cells. We mutated the single amino acid from 
alanine to valine at the 188th position of NS1 protein on an infectious clone of ZIKV 
Cambodian FSS13025 strain (FSS13025-A188V strain). FSS13025 or FSS13025-A188V 
strain (0.01 M.O.I.) was used to infect Vero cells. Supernatants from the infected Vero cells 
were collected from 0 to 5 days post-infection. a, The amount of ZIKV NS1 protein was 
determined by ELISA. b, ZIKV titer was determined by a plaque assay. c, NS1 quantity 
normalized against average viral titer (ng per pfu). The data were pooled from 3 independent 
biological replicates.
d–e, NS1 secretability determined ZIKV infectivity in mosquitoes. The supernatant, isolated 
from the FSS13025-infected or FSS13025-A188V-infected Vero cells, was premixed with 
fresh human blood at a 1:1 ratio for an in vitro membrane feeding experiment (final titer is 
5×104 pfu/ml), respectively. The fed mosquitoes were scarified on 8 days after a blood meal 
to determine the ZIKV load by qPCR. The number of infected mosquitoes relative to the 
total number of mosquitoes (infected number/total number) is shown at the top of each 
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column. Each dot represents a mosquito (d). The data are represented as the percentage of 
mosquito infections (e). The data were pooled from 3 independent biological replicates.
Data are mean ± s.e.m. (a-c). p values were determined by two-tailed Mann-Whitney test (a-
d) or two-sided Fisher’s exact test (e). *p< 0.05, **p< 0.01, n.s., not significant.
Extended Data Figure 8. Neutralization of NS1 by murine ZIKV NS1 antisera effectively 
reduced the prevalence of FSS13025-A188V ZIKV in A. aegypti
a, b, Infection by FSS13025-A188V ZIKV in AG6 mice. The AG6 mice were intradermally 
inoculated with these viruses (1×104 pfu). ZIKV NS1 measurement by ELISA. Mouse sera 
were collected to qualify the amounts of ZIKV NS1 protein from days 0 to 6 post-mouse 
infection (a). Detection of the ZIKV load in the blood of infected AG6 mice. The presence 
of infectious ZIKV particles in blood plasma was determined by a plaque assay (b). n=10 
mice per group pooled from 4 independent biological replicates.
c, d, Immuno-blockade of NS1 in the FSS13025-A188V ZIKV infected AG6 mice reduced 
the acquisition of fed A. aegypti (n=7 mice per group pooled from 3 independent biological 
replicates). The number of infected mosquitoes relative to the total number of mosquitoes is 
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shown at the top of each column. Each dot represents a mosquito (c). The data are 
represented as the percentage of mosquito infection (d).
Data are mean ± s.e.m. (a, b). p values were determined by two-tailed Mann-Whitney test 
(a-c) or two-sided Fisher’s exact test (d). *p< 0.05, ***p< 0.001, n.s., not significant.
Extended Data Figure 9. Sequence alignment of NS1 sequences in African ZIKV isolates, and 
NS1 secretability in African ZIKV-infected Vero cells
a, Sequence alignment of NS1 sequences in African ZIKV isolates.
b-d, NS1 secretability in African ZIKV-infected Vero cells. Vero cells were infected at an 
M.O.I. of 0.01 with the GZ01, FSS13025 and MR766 strains. Supernatants from the infected 
Vero cells were collected from 0 to 4 days post-infection. b, ZIKV titer was determined by a 
plaque assay. c, The amount of ZIKV NS1 protein was determined by ELISA. d, NS1 
quantity normalized against average viral titer (ng per pfu). The data were pooled from 3 
independent biological replicates.
The values in the graph represent the mean ± s.e.m. (b-d).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Comparing the infectivity of ZIKV isolates of Asian lineage in mosquitoes
a, Schematic representation of the study design. Separated groups of AG6 mice were 
intradermally infected with 1×104 pfu of the GZ01 and FSS13025 strains.
b, Detection of the ZIKV load in the blood plasma by a plaque assay (n=14 mice per group 
pooled from 5 independent biological replicates).
c, ZIKV NS1 measurement by ELISA (n=6 mice per group pooled from 3 independent 
biological replicates).
d, e, Comparison of the infectivity of two ZIKV isolates in A. aegypti (n=6 mice per group 
pooled from 3 independent biological replicates). The number at the top of each column 
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represents infected number/total number. Each dot represents a mosquito (d). The data are 
represented as the percentage of mosquito infections (e).
Data are mean ± s.e.m. (b, c). p values were determined by two-tailed Mann-Whitney test 
(b-d) or two-sided Fisher’s exact test (e). **p< 0.01, ***p< 0.001, n.s., not significant.
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Figure 2. Differences in NS1 secretion determine ZIKV infectivity in mosquitoes
a-c, NS1 secretability in ZIKV-infected Vero cells. Vero cells were infected with 0.01 M.O.I. 
viruses. c, NS1 quantity normalized against average viral titer (ng per pfu). The data were 
pooled from 3 independent biological replicates.
d-f, Immunoblockade of NS1 in GZ01-infected supernatants reduced ZIKV acquisition. 
Either 10 μl of murine ZIKV NS1 antisera or pre-immune sera were mixed with supernatant 
from ZIKV GZ01-infected Vero cells (500 μl) and fresh human blood (500 μl) for in vitro 
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membrane feeding of A. aegypti. The data were pooled from 2 independent biological 
replicates.
g-i, Addition of NS1 in FSS13025-infected supernatant increased the mosquito infection. 
Either 10 μg of purified NS1 or BSA was incubated with fresh human blood (500 μl) and 
supernatant from ZIKV FSS13025-infected Vero cells (500 μl) to feed A. aegypti. The data 
were pooled from 2 independent biological replicates.
j-l, Assessment of the threshold NS1 concentration that enhances ZIKV acquisition. Serial 
dilutions of purified ZIKV NS1 (10 μl) were mixed with purified GZ01 ZIKV virions (10 μl) 
and fresh human blood (1000 μl) for A. aegypti feeding. The data were pooled from 4 
independent biological replicates.
A final concentration of 1×105 pfu/ml ZIKV was used for mosquito oral infection (d, g, j).
The number at the top of each column represents infected number/total number. Each dot 
represents a mosquito (e, h, k).
Data are mean ± s.e.m. (a-c). p values were determined by two-tailed Mann-Whitney test (e, 
h, k) or two-sided Fisher’s exact test (f, i, l), and adjusted using Bonferroni correction to 
account for multiple comparisons (k, l). The p value represents a comparison between BSA 
and other groups (k, l). *p< 0.0125, ***p< 0.00025, n.s., not significant.
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Figure 3. A single amino acid residue in NS1 determines its secretability in the Asian lineage of 
ZIKV
a, Comparison of the prM-E-NS1 sequence between GZ01 and FSS13025 isolates.
b, Detection of NS1 secretion in ectopically expressed prM-E-NS1 proteins of the subcloned 
and mutated GZ01 and FSS13025 strains.
c, Detection of NS1 secretion in ectopically expressed prM-E-NS1 proteins of ZIKV Asian 
strains.
d, Mutation of alanine to valine in the NS1 protein conferred NS1 secretability to the prM-
E-NS1 proteins of a Malaysia P6-740 strain.
b-d, The experiments were reproduced 3 times with similar results. For gel source data, see 
Supplementary Fig. 1.
e, Measurement of ZIKV NS1 antigenemia by ELISA (n=10 mice per group pooled from 5 
independent biological replicates).
f, Detection of the ZIKV load in the mouse blood by a plaque assay (n=8 mice per group 
pooled from 4 independent biological replicates).
g, h, Comparison of mosquito infectivity (g) and infective ratio (h) of ZIKV strains (n=6 
mice per group pooled from 3 independent biological replicates). The number at the top of 
each column represents infected number/total number. Each dot represents a mosquito (g).
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The AG6 mice were intradermally inoculated with 1×104 pfu of the FSS13025 and 
FSS13025-A188V strains, data are mean ± s.e.m. (e, f). p values were determined by two-
tailed Mann-Whitney test (e-g) or two-sided Fisher’s exact test (h). *p< 0.05, ***p< 0.001, 
n.s., not significant.
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Figure 4. A single amino acid substitution influences the prevalence of mosquito infection during 
the "mosquito-host-mosquito" life cycle
a, Schematic representation of the study design.
b, Detection of the ZIKV viremia by a plaque assay (n=12 mice per group pooled from 4 
independent biological replicates).
c, Measurements of ZIKV NS1 antigenemia by ELISA (n=12 mice per group pooled from 4 
independent biological replicates).
d, e, Comparison of mosquito infectivity (d) and infective ratio (e) of ZIKV strains (n=9 
mice per group pooled from 3 independent biological replicates). The number at the top of 
each column represents infected number/total number. Each dot represents a mosquito (d).
Data are mean ± s.e.m. (b, c). p values were determined by two-tailed Mann-Whitney test 
(b-d) or two-sided Fisher’s exact test (e), and adjusted using Bonferroni correction to 
account for multiple comparisons (b-e). The black p value represents a comparison between 
GZ01 and FSS13025. The blue p value represents a comparison between FSS13025-A188V 
and FSS13025. *p< 0.025, **p< 0.005, ***p< 0.0005, n.s., not significant.
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